UNSPSC 51162339: Atropine/chlorpheniramine/ephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162339 Atropine/chlorpheniramine/ephedrine is a Commodity code covering pharmaceutical products that state and local governments procure primarily for correctional healthcare, emergency medical response, and community health initiatives. Recent solicitations show state and local buyers purchasing parenteral nutrition solutions, intravenous products, and emergency medications including naloxone through competitive bidding. The Washington State Department of Corrections and Seminole County, Florida represent the primary recent buyers, with DOC seeking suppliers capable of rapid preparation and delivery of customized parenteral products to multiple facilities and Seminole County procuring naloxone and drug deactivation systems for community health distribution.

The code shows activity concentrated in Washington and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a response deadline of October 7, 2026, seeking parenteral products and services for eight correctional facilities across the state with deliveries required within 24 hours for specialized products and 8 hours for standard parenteral supplies; DOC indicated it may award up to three contractors per region and encourages participation from small, minority-owned, women-owned, and veteran-owned businesses under Chapter 39.19 RCW. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with responses due July 26, 2026, and a two-year initial contract term with renewal option.